Literature DB >> 2912441

Staurosporine, a protein kinase C inhibitor interferes with proliferation of arterial smooth muscle cells.

H Matsumoto1, Y Sasaki.   

Abstract

Staurosporine (10 ng/ml and more), a protein kinase C inhibitor, inhibited the serum-stimulated growth of smooth muscle cells. This inhibitory effect proved to be linked to the inhibition of transition from the G0 to the S phase of the cell cycle, as measured by 5-bromodeoxyuridine incorporation into the nuclei. As this inhibitory effect of staurosporine was restricted to the first 10 hours of the stimulation, reactions which are essential for the signal transduction may be associated with actions of protein kinase C. The possibility that staurosporine may inhibit cell growth via inhibition of this step warrants further attention.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2912441     DOI: 10.1016/s0006-291x(89)80183-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  CXC chemokine receptor 4 expression and stromal cell-derived factor-1alpha-induced chemotaxis in CD4+ T lymphocytes are regulated by interleukin-4 and interleukin-10.

Authors:  T Jinquan; S Quan; H H Jacobi; H O Madsen; C Glue; P S Skov; H J Malling; L K Poulsen
Journal:  Immunology       Date:  2000-03       Impact factor: 7.397

2.  MALDI-TOF MS as a label-free approach to rapid inhibitor screening.

Authors:  Kenneth D Greis; Songtao Zhou; Thomas M Burt; Andrew N Carr; Elizabeth Dolan; Vijayasurian Easwaran; Artem Evdokimov; Richard Kawamoto; Jeff Roesgen; Gregory F Davis
Journal:  J Am Soc Mass Spectrom       Date:  2006-04-17       Impact factor: 3.109

3.  Assay principle for modulators of protein-protein interactions and its application to non-ATP-competitive ligands targeting protein kinase A.

Authors:  S Adrian Saldanha; Gregory Kaler; Howard B Cottam; Ruben Abagyan; Susan S Taylor
Journal:  Anal Chem       Date:  2006-12-15       Impact factor: 6.986

4.  Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C.

Authors:  A C Newby; K Lim; M A Evans; N P Brindle; R F Booth
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

5.  Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1.

Authors:  R M Böhmer; E Scharf; R K Assoian
Journal:  Mol Biol Cell       Date:  1996-01       Impact factor: 4.138

6.  Enhanced superoxide release and elevated protein kinase C activity in neutrophils from diabetic patients: association with periodontitis.

Authors:  M Karima; A Kantarci; T Ohira; H Hasturk; V L Jones; B-H Nam; A Malabanan; P C Trackman; J A Badwey; T E Van Dyke
Journal:  J Leukoc Biol       Date:  2005-08-04       Impact factor: 4.962

Review 7.  Therapeutic potential of protein kinase C inhibitors.

Authors:  D Bradshaw; C H Hill; J S Nixon; S E Wilkinson
Journal:  Agents Actions       Date:  1993-01

8.  A subset of signal transduction pathways is required for hippocampal growth cone collapse induced by ephrin-A5.

Authors:  Xin Yue; Cheryl Dreyfus; Tony Ah-Ng Kong; Renping Zhou
Journal:  Dev Neurobiol       Date:  2008-09-01       Impact factor: 3.964

9.  Protein kinase C and adenylate cyclase as targets for growth inhibition of human gastric cancer cells.

Authors:  M Piontek; K J Hengels; R Porschen; G Strohmeyer
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

10.  Glucose-induced changes in Na+/H+ antiport activity and gene expression in cultured vascular smooth muscle cells. Role of protein kinase C.

Authors:  B Williams; R L Howard
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.